Suchergebnisse - "Sebastian, Shaji"

PubPharm (25)

1

Antibody Responses to Influenza Vaccination are Diminished in Patients With Inflammatory Bowel Disease on Infliximab or Tofacitinib

enthalten in: Journal of Crohn's & colitis | 2024

von Liu, Z. | Alexander, J. | Yee Eng, K. | +30

2

Modern practical management of acute severe colitis

enthalten in: Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology | 2024

von AbdelMeguid, A. | Whitehead, E. | Sebastian, S.

3

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD) : an analysis of a prospective multicentre cohort study

enthalten in: The lancet. Gastroenterology & hepatology | 2023

von Liu, Z. | Le, K. | Zhou, X. | +120

CommentIn: Lancet Gastroenterol Hepatol. 2023 Feb;8(2):99-100. - PMID 36481042

4

Vaccine escape, increased breakthrough and reinfection in infliximab-treated patients with IBD during the Omicron wave of the SARS-CoV-2 pandemic

enthalten in: Gut | 2023

von Kennedy, N. | Janjua, M. | Chanchlani, N. | +20

5

Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine

enthalten in: Gastroenterology | 2023

von Liu, Z. | Alexander, J. | Lin, K. | +70

6

The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients

enthalten in: EBioMedicine | 2023

von Alexander, J. | Mullish, B. | Danckert, N. | +24

7

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP) : a multicentre, prospective, case-control study

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Alexander, J. | Liu, Z. | Muñoz Sandoval, D. | +67

8

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease : results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Chanchlani, N. | Lin, S. | Auth, M. | +99

CommentIn: Aliment Pharmacol Ther. 2022 Oct;56(8):1294-1295. - PMID 36168263

9

Patient preferences and current practice for adults with steroid-resistant ulcerative colitis : POPSTER mixed-methods study

enthalten in: Health technology assessment (Winchester, England) | 2022

von Coates, E. | Wickramasekera, N. | Barr, A. | +10

10

Prediction of Relapse After Anti-Tumor Necrosis Factor Cessation in Crohn's Disease : Individual Participant Data Meta-analysis of 1317 Patients From 14 Studies

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Pauwels, R. | van der Woude, C. | Nieboer, D. | +55

CommentIn: Clin Gastroenterol Hepatol. 2022 Aug;20(8):1668-1670. - PMID 34058414